Wellspring Biosciences, Inc.

Kura Oncology, Inc. is on a mission to treat a broad range of blood and solid cancers using two novel protein targets that offer strong combination potential. The US firm was founded in 2014 but its

In February, the Johnson & Johnson unit Janssen Biotech Inc. announced a collaboration with Araxes Pharma LLC , a start-up predicated on work out of the University of California, San Fran

Johnson & Johnson ’s Janssen Pharmaceuticals subsidiary plans to stay ahead of the anticipated 4.5% drug industry growth with a pipeline that relies heavily on external innovation, as well as the u

Financings – Biopharma financing had a strong start in 2013; the first quarter – with 86 biopharma financings bringing in $4.6 billion – already exceeding Q4 2012, last year’s strongest quarter, which